ArticleCancers2025

Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.

Yudai Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.